Issn Print: 1522-8517
Publication Date: 2017/06/01
MEK and RAF inhibitors: time for a paradigm shift in the treatment of pediatric low-grade gliomas?
Maryam Fouladi; Stefan M. Pfister
Author Information: Brain Tumor Center, Cancer and Blood Disorders Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio (M.F.); Division of Pediatric Neuro-oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany (S.M.P.)
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.